Effect of antisense TIMP-1 cDNA on the expression of TIMP-1 and MMP-2 in lung tissue with pulmonary fibrosis induced by bleomycin

Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T and Ando M: Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 62:1949–1956. 2000. View Article : Google Scholar

Lagente V, Manoury B, Nénan S, Le Quément C, Martin-Chouly C and Boichot E: Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res. 38:1521–30. 2005. View Article : Google Scholar : PubMed/NCBI

Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ and Travis WD: Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol. 149:1241–1256. 1996.

Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M and Yamanaka N: Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest. 78:687–698. 1998.PubMed/NCBI

Finlay GA, O’Driscoll LR, Russell KJ, D’Arcy EM, Masterson JB, FitzGerald MX and O’Connor CM: Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 156:240–247. 1997. View Article : Google Scholar : PubMed/NCBI

Suzuki R, Miyazaki Y, Takagi K, Torii K and Taniguchi H: Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Treat Respir Med. 3:17–27. 2004. View Article : Google Scholar : PubMed/NCBI

Cataldo DD, Gueders MM, Rocks N, Sounni NE, Evrard B, Bartsch P, Louis R, Noel A and Foidart JM: Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand). 49:875–884. 2003.

Cox TR and Erler JT: Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. 4:165–178. 2011. View Article : Google Scholar : PubMed/NCBI

Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010. View Article : Google Scholar : PubMed/NCBI

Wu TH, Ling HL and Zhu ZM: Effect of sense and antisense TIMP-1 gene to ECM expression of mouse fibroblast cells. Zhong Guo Man Xing Bing Yu Fang Yu Kong Zhi. 12:20–23. 2004.(In Chinese).

McKeown S, Richter AG, O’Kane C, McAuley DF and Thickett DR: MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 33:77–84. 2009. View Article : Google Scholar : PubMed/NCBI

Manoury B, Nénan S, Guénon I, Lagente V and Boichot E: Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis. Int Immunopharmacol. 7:900–911. 2007. View Article : Google Scholar : PubMed/NCBI

Manoury B, Caulet-Maugendre S, Guénon I, Lagente V and Boichot E: TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol. 19:471–487. 2006.PubMed/NCBI

Tian XL, Yao W, Guo ZJ, Gu L and Zhu YJ: Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina. Chin Med Sci J. 21:145–151. 2006.PubMed/NCBI

Robbins PD and Ghivizzani SC: Viral vectors for gene therapy. Pharmacol Ther. 80:35–47. 1998. View Article : Google Scholar : PubMed/NCBI

Cook DN, Brass DM and Schwartz DA: A matrix for new ideas in pulmonary fibrosis. Am J Respir Cell Mol Biol. 27:122–124. 2002. View Article : Google Scholar : PubMed/NCBI